Phedias Diamandis, MD, PhD, FRCPC

Follow Dr. Diamandis:

Dr. Diamandis' research program aims to develop novel global molecular profiling technologies to study brain tumours, neurodevelopment and cancer stem cells.

Mol Cell Proteomics. 2017 Sep;16(9):1548-1562
Djuric U, Rodrigues DC, Batruch I, Ellis J, Shannon P, Diamandis P
J Clin Oncol. 2017 Jul 20;35(21):2386-2393
Diamandis P, Aldape KD
Brain Dev. 2017 Jan;39(1):23-39
Diamandis P, Chitayat D, Toi A, Blaser S, Shannon P
Neuromuscul Disord. 2016 Mar;26(3):201-6
Bamaga AK, Riazi S, Amburgey K, Ong S, Halliday W, Diamandis P, Guerguerian AM, Dowling JJ, Yoon G
Diagn Pathol. 2016 Jan 27;11:13
Diamandis P, Ferrer-Luna R, Huang RY, Folkerth RD, Ligon AH, Wen PY, Beroukhim R, Ligon KL, Ramkissoon SH
Childs Nerv Syst. 2015 Oct;31(10):1699-706
Thompson YY, Ramaswamy V, Diamandis P, Daniels C, Taylor MD
Brain Pathol. 2014 Jan;24(1):101-2
Diamandis P, Amato D, Finkelstein J, Keith J
Front Hum Neurosci. 2013;7:222
Hazrati LN, Tartaglia MC, Diamandis P, Davis KD, Green RE, Wennberg R, Wong JC, Ezerins L, Tator CH
Clin Proteomics. 2013 May 01;10(1):5
Begcevic I, Kosanam H, Martínez-Morillo E, Dimitromanolakis A, Diamandis P, Kuzmanov U, Hazrati LN, Diamandis EP
Cytopathology. 2014 Feb;25(1):59-61
Keith J, Pirouzmand F, Diamandis P, Ghorab Z

Pages


Neuropathologist, Department of Pathology, University Health Network
Assistant Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto